What is the opinion of sanofi-aventis regarding this registry analyses?
Sanofi-aventis considers that the registry analyses published in Diabetologia are inconclusive, as per the authors’ statements. However, in light of the alleged findings, these publications have created worries and confusion among patients and prescribers. As per the authors’ own statements, the results of the 4 registries are inconclusive. No conclusion can be drawn regarding a possible causal relationship between Lantus and the occurrence of malignancies. All papers also stressed categorically that Lantus does not cause cancer. A thorough review of our clinical trials and post-marketing data in no way confirms these findings.
